CH AllergyIntolerance (R4)
4.0.0-ballot-ci-build - ci-build
CH AllergyIntolerance (R4), published by HL7 Switzerland. This guide is not an authorized publication; it is the continuous build for version 4.0.0-ballot-ci-build built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7ch/ch-allergyintolerance/ and changes regularly. See the Directory of published versions
<AllergyIntolerance xmlns="http://hl7.org/fhir">
<id value="CH-AllergyIntolerance-Usecase-2"/>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: AllergyIntolerance CH-AllergyIntolerance-Usecase-2</b></p><a name="CH-AllergyIntolerance-Usecase-2"> </a><a name="hcCH-AllergyIntolerance-Usecase-2"> </a><a name="CH-AllergyIntolerance-Usecase-2-en-US"> </a><p><b>Abatement</b>: 2022-02-07</p><p><b>clinicalStatus</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical active}">Active</span></p><p><b>verificationStatus</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/allergyintolerance-verification unconfirmed}">Unconfirmed</span></p><p><b>type</b>: Allergy</p><p><b>category</b>: Medication</p><p><b>criticality</b>: Low Risk</p><p><b>code</b>: <span title="Codes:{http://snomed.info/sct 860765003}">Allergy to thiazide (finding)</span></p><p><b>patient</b>: <a href="Patient-ElisabethBroennimannByBFH.html">Elisabeth Brönnimann-Bertholet Female, DoB: 1937-05-03</a></p><h3>Reactions</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Substance</b></td><td><b>Manifestation</b></td><td><b>Severity</b></td><td><b>ExposureRoute</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://snomed.info/sct 387525002}">Hydrochlorothiazide (substance)</span></td><td><span title="Codes:{http://snomed.info/sct 126485001}">Urticaria (disorder)</span></td><td>Moderate</td><td><span title="Codes:{http://snomed.info/sct 26643006}">Oral route (qualifier value)</span></td></tr></table></div>
</text>
<extension
url="http://hl7.org/fhir/StructureDefinition/allergyintolerance-abatement">
<valueDateTime value="2022-02-07"/>
</extension>
<clinicalStatus>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical"/>
<code value="active"/>
<display value="Active"/>
</coding>
</clinicalStatus>
<verificationStatus>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/allergyintolerance-verification"/>
<code value="unconfirmed"/>
<display value="Unconfirmed"/>
</coding>
</verificationStatus>
<type value="allergy"/>
<category value="medication"/>
<criticality value="low"/>
<code>
<coding>
<system value="http://snomed.info/sct"/>
<code value="860765003"/>
<display value="Allergy to thiazide (finding)"/>
</coding>
</code>
<patient>🔗
<reference value="Patient/ElisabethBroennimannByBFH"/>
</patient>
<reaction>
<substance>
<coding>
<system value="http://snomed.info/sct"/>
<code value="387525002"/>
<display value="Hydrochlorothiazide (substance)"/>
</coding>
</substance>
<manifestation>
<coding>
<system value="http://snomed.info/sct"/>
<code value="126485001"/>
<display value="Urticaria (disorder)"/>
</coding>
</manifestation>
<severity value="moderate"/>
<exposureRoute>
<coding>
<system value="http://snomed.info/sct"/>
<code value="26643006"/>
<display value="Oral route (qualifier value)"/>
</coding>
</exposureRoute>
</reaction>
</AllergyIntolerance>